Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study37

File Visits

Downloads
41131-1808.pdf11

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study21

Number of downloads in the range

Downloads
41131-1808.pdf1

Views

Views
January 20250
February 20250
March 20257
April 202511
May 20253
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • January 2025
    0
  • February 2025
    0
  • March 2025
    0
  • April 2025
    1
  • May 2025
    0
  • June 2025
    0
  • July 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Singapore7
United States2
Spain1
Mexico1
 

Top countries by downloads

Downloads
Hong Kong1
 

Top cities views

Views
Hong Kong10
Council Bluffs1
Gustavo Adolfo Madero1
Palma1
 

Top cities by downloads

Downloads
Hong Kong1